CCR5-tropic virus is the predominant virus encountered, though CXCR4-tropic virus strains are more likely encountered, in patients with advanced HIV disease. Results from Phase III clinical trials ...

orally bioavailable CXCR4 antagonist CXCR4 and CCR5 are the two major coreceptors for HIV-1 infection. Coreceptors are responsible for a crucial step between Env binding to the receptor CD4 and ...

In its analysis, CytoDyn zeroed in on a subgroup of 62 critically ill patients on ventilation who were treated with the CCR5 antagonist, arguing that it significantly reduced all-cause mortality ...

Department of Immunology, Zunyi Medical University; Guizhou Provincial Research Center for Applied Immunomolecular Engineering; Guizhou Provincial Innovation Base for Graduate Education in Immunology; ...

Chief of Staff: Claire Mullen Acting Director, Values and Ethics: Meriem Sekhi Director and Chief Audit Executive: Marie-Josée Yelle Special Advisor to the Deputy Minister: Manish Srivastava ...